---
schema_version: "secwatch.filing_event.v1"
accession: "0000785161-25-000118"
form_type: "8-K"
ticker: "EHC"
cik: "0000785161"
company_name: "Encompass Health Corp"
filed_at: "2025-12-01T23:59:59+00:00"
generated_at: "2026-05-16T15:57:41.696620+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Encompass Health reaffirms full-year 2025 guidance ahead of investor meetings

## Summary
- Net operating revenue expected $5,905M to $5,955M.
- Adjusted EBITDA guidance range of $1,235M to $1,255M.
- Adjusted EPS from continuing ops attributed to Encompass Health: $5.22 to $5.37.
- Management to meet investors December 2–3, 2025; guidance unchanged from Oct 29, 2025.

## SEC filing metadata
- accession: 0000785161-25-000118
- form_type: 8-K
- ticker: EHC
- cik: 0000785161
- company_name: Encompass Health Corp
- filed_at: 2025-12-01T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/785161/000078516125000118/0000785161-25-000118-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/785161/000078516125000118/ehc-20251201.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000785161-25-000118
- JSON: https://secwatch.observer/filing/0000785161-25-000118.json
- Plain text: https://secwatch.observer/filing/0000785161-25-000118.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.